Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Definitive Healthcare Corp (DH)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
03/27/2025: DH (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -66.77% | Avg. Invested days 20 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 03/27/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 298.09M USD | Price to earnings Ratio - | 1Y Target Price 4.75 |
Price to earnings Ratio - | 1Y Target Price 4.75 | ||
Volume (30-day avg) 1161584 | Beta 1.51 | 52 Weeks Range 2.54 - 8.33 | Updated Date 04/2/2025 |
52 Weeks Range 2.54 - 8.33 | Updated Date 04/2/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -3.54 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -163.81% | Operating Margin (TTM) 0.53% |
Management Effectiveness
Return on Assets (TTM) -0.42% | Return on Equity (TTM) -65.49% |
Valuation
Trailing PE - | Forward PE 13.79 | Enterprise Value 261033898 | Price to Sales(TTM) 1.18 |
Enterprise Value 261033898 | Price to Sales(TTM) 1.18 | ||
Enterprise Value to Revenue 1.15 | Enterprise Value to EBITDA 46.69 | Shares Outstanding 112911000 | Shares Floating 40803895 |
Shares Outstanding 112911000 | Shares Floating 40803895 | ||
Percent Insiders 7.13 | Percent Institutions 94.68 |
Analyst Ratings
Rating 3.5 | Target Price 5.25 | Buy - | Strong Buy 4 |
Buy - | Strong Buy 4 | ||
Hold 9 | Sell 1 | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Definitive Healthcare Corp
Company Overview
History and Background
Definitive Healthcare Corp was founded in 2011. It provides comprehensive data and analytics on the healthcare provider market.
Core Business Areas
- Commercial Intelligence: Provides detailed information and insights on healthcare providers and organizations to support sales, marketing, and strategy decisions.
- Analytics and Data: Offers analytical tools and datasets to analyze market trends, identify opportunities, and assess competitive landscapes within the healthcare sector.
Leadership and Structure
Robert Musslewhite is the Chief Executive Officer. The company has a typical corporate structure with departments like sales, marketing, technology, and finance.
Top Products and Market Share
Key Offerings
- HospitalView: Provides detailed information on hospitals, including financial performance, technology adoption, and affiliations. Competitors include Zoominfo (ZI), Healthgrades, and Premier Inc (PINC). Data on market share and revenue are not publicly available at the product level.
- PhysicianView: Offers data on physicians, including their specialties, affiliations, and prescribing patterns. Competitors include Zoominfo (ZI), Healthgrades, and Doximity (DOCS). Data on market share and revenue are not publicly available at the product level.
Market Dynamics
Industry Overview
The healthcare data and analytics market is growing due to the increasing demand for data-driven insights to improve healthcare delivery, reduce costs, and enhance patient outcomes.
Positioning
Definitive Healthcare is positioned as a provider of comprehensive healthcare data and analytics solutions, catering to various stakeholders including healthcare providers, life sciences companies, and financial institutions.
Total Addressable Market (TAM)
The TAM for healthcare data and analytics is estimated to be in the tens of billions of dollars. Definitive Healthcare is positioned to capture a significant portion of this market.
Upturn SWOT Analysis
Strengths
- Comprehensive healthcare data
- Strong analytics platform
- Established customer base
- Experienced management team
Weaknesses
- High customer concentration
- Integration risks from acquisitions
- Dependence on data quality
- Competition with larger, more diversified players
Opportunities
- Expansion into new markets
- Development of new products and services
- Strategic partnerships
- Increased demand for healthcare data analytics
Threats
- Economic downturns
- Data privacy regulations
- Increased competition
- Technological changes
Competitors and Market Share
Key Competitors
- ZI
- DOCS
- PINC
Competitive Landscape
Definitive Healthcare competes with various companies, including larger, more diversified players. Its competitive advantage lies in its comprehensive healthcare data and analytics platform.
Major Acquisitions
Monocl Strategy AB
- Year: 2021
- Acquisition Price (USD millions): 125
- Strategic Rationale: Expanded Definitive Healthcare's international presence and enhanced its data and analytics capabilities.
Growth Trajectory and Initiatives
Historical Growth: Definitive Healthcare has experienced revenue growth, driven by increased demand for its data and analytics solutions.
Future Projections: Future growth is expected to be driven by continued demand for healthcare data analytics and expansion into new markets.
Recent Initiatives: Recent strategic initiatives include acquisitions to expand its product offerings and investments in technology to improve its analytics platform.
Summary
Definitive Healthcare is a key player in the growing healthcare data and analytics market, offering comprehensive solutions and a strong analytics platform. While they face stiff competition and depend on the quality of their data, strategic acquisitions and expansion initiatives position them well for future growth. High customer concentration poses a risk, but continuous market expansion is key to sustained success. The company doesn't pay dividends, prioritizing growth investments over shareholder payouts.
Similar Companies
ALLO
Allogene Therapeutics Inc
ALLO
Allogene Therapeutics Inc
CNMD
CONMED Corporation
CNMD
CONMED Corporation
DOCS
Doximity Inc
DOCS
Doximity Inc
ZI
ZoomInfo Technologies Inc
ZI
ZoomInfo Technologies Inc
Sources and Disclaimers
Data Sources:
- Company filings
- Analyst reports
- Industry publications
Disclaimers:
The information provided is for informational purposes only and should not be considered as investment advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Definitive Healthcare Corp
Exchange NASDAQ | Headquaters Framingham, MA, United States | ||
IPO Launch date 2021-09-15 | CEO & Director Mr. Kevin D. Coop | ||
Sector Healthcare | Industry Health Information Services | Full time employees 782 | Website https://www.definitivehc.com |
Full time employees 782 | Website https://www.definitivehc.com | ||
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.